Question: is oprelvekin used for thrombocytopenia?
Answer: Oprelvekin (Neumega) is a recombinant IL-11 that is approved for the prevention of severe thrombocytopenia and also for the reduction of the need for platelet transfusions following myelosuppressive chemotherapy in adult patients with nonmyeloid malignancies who are at high risk of severe thrombocytopenia.